MYDA Advisors »

Crispr Therapeutics shares owned by MYDA Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by MYDA Advisors from 13F filings

Historical chart of MYDA Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by MYDA Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by MYDA Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $787k 15k 52.44
2022-09-30 $327k 5.0k 65.40
2022-06-30 $608k 10k 60.80
2019-12-31 $853k 14k 60.93